Siagoside

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameSiagoside
Drug Alias NameAgF2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFidia Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThomas Jefferson University
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A